Literature DB >> 24709119

MicroRNA (miRNA): sequence and stability, viroid-like properties, and disease association in the CNS.

Aileen I Pogue1, James M Hill2, Walter J Lukiw3.   

Abstract

MicroRNAs (miRNAs) constitute a relatively recently-discovered class of small non-coding RNAs (sncRNAs) that are gaining considerable attention in the molecular-genetic regulatory mechanisms that contribute to human health and disease. As highly soluble and mobile entities, emerging evidence indicates that miRNAs posess a highly selected ribonucleotide sequence structure, are part of an evolutionary ancient genetic signaling system, resemble the plant pathogens known as viroids in their structure, mode of generation and function, and are very abundant in the physiological fluids that surround cells and tissues. Persistence and altered abundance of miRNAs in the extracellular fluid (ECF) or cerebrospinal fluid (CSF) may play a role in the intercellular spreading of disease systemically, and throughout functionally-linked cellular and tissue systems such as the central nervous system (CNS). This short communication will review some of the more fascinating features of these highly structured single stranded RNAs (ssRNAs) with emphasis on their presence and function in the human CNS, with particular reference to Alzheimer׳s disease (AD) wherever possible.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer׳s disease; CSF; ECF; Endocrine; Evolution; MicroRNA (miRNA); Neurological disease; Paracrine; Stability; Translocation; Transmissibility; Viroids

Mesh:

Substances:

Year:  2014        PMID: 24709119      PMCID: PMC4175085          DOI: 10.1016/j.brainres.2014.03.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  80 in total

1.  A gene expression profile of Alzheimer's disease.

Authors:  J F Loring; X Wen; J M Lee; J Seilhamer; R Somogyi
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

Review 2.  The origin and evolution of model organisms.

Authors:  S Blair Hedges
Journal:  Nat Rev Genet       Date:  2002-11       Impact factor: 53.242

3.  In vivo microRNA detection and quantitation in cerebrospinal fluid.

Authors:  Juan A Gallego; Marc L Gordon; Kierstyn Claycomb; Mahima Bhatt; Todd Lencz; Anil K Malhotra
Journal:  J Mol Neurosci       Date:  2012-03-09       Impact factor: 3.444

Review 4.  Viroid-specific small RNA in plant disease.

Authors:  Christian Hammann; Gerhard Steger
Journal:  RNA Biol       Date:  2012-05-23       Impact factor: 4.652

Review 5.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

6.  Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease.

Authors:  Jian-Guo Cui; James M Hill; Yuhai Zhao; Walter J Lukiw
Journal:  Neuroreport       Date:  2007-01-22       Impact factor: 1.837

Review 7.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

8.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

9.  Alzheimer's disease and retinal neurodegeneration share a consistent stress response of the neurovascular unit.

Authors:  Stephanie Busch; Liang Wu; Yuxi Feng; Norbert Gretz; Sigrid Hoffmann; Hans-Peter Hammes
Journal:  Cell Physiol Biochem       Date:  2012-11-22

10.  MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state.

Authors:  Reuben Saba; Shantel Gushue; Rhiannon L C H Huzarewich; Kathy Manguiat; Sarah Medina; Catherine Robertson; Stephanie A Booth
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more
  17 in total

Review 1.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 2.  Analysis of RNA from Alzheimer's Disease Post-mortem Brain Tissues.

Authors:  Christian Clement; James M Hill; Prerna Dua; Frank Culicchia; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

Review 3.  Plant and Animal microRNAs (miRNAs) and Their Potential for Inter-kingdom Communication.

Authors:  Yuhai Zhao; Lin Cong; Walter J Lukiw
Journal:  Cell Mol Neurobiol       Date:  2017-09-06       Impact factor: 5.046

4.  Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.

Authors:  Christine Schwienbacher; Luisa Foco; Anne Picard; Eloina Corradi; Alice Serafin; Jörg Panzer; Stefano Zanigni; Hagen Blankenburg; Maurizio F Facheris; Giulia Giannini; Marika Falla; Pietro Cortelli; Peter P Pramstaller; Andrew A Hicks
Journal:  J Mol Neurosci       Date:  2017-05-24       Impact factor: 3.444

5.  Fission Impossible: Stabilized miRNA-Based Analogs in Neurodegenerative Disease.

Authors:  Walter J Lukiw
Journal:  Front Neurosci       Date:  2022-05-03       Impact factor: 5.152

Review 6.  MicroRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD).

Authors:  James M Hill; Walter J Lukiw
Journal:  Neurochem Res       Date:  2015-10-06       Impact factor: 3.996

7.  Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).

Authors:  James M Hill; Christian Clement; Aileen I Pogue; Surjyadipta Bhattacharjee; Yuhai Zhao; Walter J Lukiw
Journal:  Front Aging Neurosci       Date:  2014-06-16       Impact factor: 5.750

8.  An evaluation of progressive amyloidogenic and pro-inflammatory change in the primary visual cortex and retina in Alzheimer's disease (AD).

Authors:  James M Hill; Prerna Dua; Christian Clement; Walter J Lukiw
Journal:  Front Neurosci       Date:  2014-11-12       Impact factor: 4.677

9.  Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease.

Authors:  Yuhai Zhao; Peter N Alexandrov; Walter J Lukiw
Journal:  Front Neurosci       Date:  2016-02-25       Impact factor: 4.677

10.  microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration.

Authors:  Surjyadipta Bhattacharjee; Yuhai Zhao; Prerna Dua; Evgeny I Rogaev; Walter J Lukiw
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.